245 related articles for article (PubMed ID: 18727427)
1. [The morphofunctional characteristics of proteins of nucleolar organizers in uterine smooth muscle tumors].
Bobrov IP; Avdalian AM; Lazarev AF; Klimachev VV; Klimacheva TB; Mishchenko EV
Arkh Patol; 2008; 70(3):18-23. PubMed ID: 18727427
[TBL] [Abstract][Full Text] [Related]
2. [Association of expression of progesterone and estrogen-alpha receptors with the activity of argyrophilic proteins in nucleolar organizer regions in smooth muscle tumors of the corpus uteri].
Avdalian AM; Bobrov IP; Klimachev VV; Chechulin MN; Lazarev AF
Arkh Patol; 2009; 71(4):50-3. PubMed ID: 19824432
[TBL] [Abstract][Full Text] [Related]
3. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
4. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
Mittal K; Demopoulos RI
Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
[TBL] [Abstract][Full Text] [Related]
5. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
Shi YF; Xie X; Zhao CL
Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
[TBL] [Abstract][Full Text] [Related]
6. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
7. PTEN, tau-AP-3, thymidylate synthase immunohistochemistry scoring expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignancy potential and uterine leiomyosarcomas.
Huang LC; Ye JC; Hsieh CH; Chen LM; Lin TY; Hung YC; Chang WC
Eur J Gynaecol Oncol; 2011; 32(5):496-9. PubMed ID: 22053660
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of calponin h1 in leiomyosarcoma of the uterus.
Horiuchi A; Nikaido T; Ito K; Zhai Y; Orii A; Taniguchi S; Toki T; Fujii S
Lab Invest; 1998 Jul; 78(7):839-46. PubMed ID: 9690561
[TBL] [Abstract][Full Text] [Related]
9. [Sex hormones receptor expression and the activity of the argyrophilic proteins of the nucleolar organizer region in the intact myometrium cells and in uterine leiomyoma].
Avdalian AM; Bobrov IP; Klimachev VV; Lazarev AF
Morfologiia; 2010; 137(2):61-5. PubMed ID: 20572398
[TBL] [Abstract][Full Text] [Related]
10. [Clinical pathology of uterine smooth muscle tumors--borderline lesions between leiomyomas and leiomyosarcomas].
Fujii S
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):385-90. PubMed ID: 3361191
[No Abstract] [Full Text] [Related]
11. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
[TBL] [Abstract][Full Text] [Related]
12. Pathologic considerations of uterine smooth muscle tumors.
Prayson RA; Hart WR
Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulatory markers in uterine atypical leiomyoma and leiomyosarcoma: immunohistochemical study of 68 cases with clinical follow-up.
Mills AM; Ly A; Balzer BL; Hendrickson MR; Kempson RL; McKenney JK; Longacre TA
Am J Surg Pathol; 2013 May; 37(5):634-42. PubMed ID: 23552380
[TBL] [Abstract][Full Text] [Related]
14. Treatment of huge uterine tumors thought to be benign in post-menopausal women.
Okamoto T; Koshiyama M; Yamamoto K
Med Sci Monit; 2004 Feb; 10(2):CR43-5. PubMed ID: 14737041
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma.
Leiser AL; Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi DS; Soslow RA
Gynecol Oncol; 2006 Apr; 101(1):86-91. PubMed ID: 16289259
[TBL] [Abstract][Full Text] [Related]
16. Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics.
Watanabe K; Suzuki T
Histopathology; 2006 Apr; 48(5):563-8. PubMed ID: 16623782
[TBL] [Abstract][Full Text] [Related]
17. DOG1 immunoreactivity in uterine leiomyosarcomas.
Sah SP; McCluggage WG
J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
[TBL] [Abstract][Full Text] [Related]
18. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
Burns B; Curry RH; Bell ME
Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641
[TBL] [Abstract][Full Text] [Related]
19. HMB-45 reactivity in renal leiomyomas and leiomyosarcomas.
Bonsib SM
Mod Pathol; 1996 Jun; 9(6):664-9. PubMed ID: 8782205
[TBL] [Abstract][Full Text] [Related]
20. [Expression of bcl-2 and bax protein in uterine leiomyosarcomas and leiomyomas].
Zhang ZL; Zhang Y; Zhou JH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):183-6. PubMed ID: 15898430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
